Safety and survival outcomes of 177Lu-prostate-specific membrane antigen therapy in patients with metastatic castration-resistant prostate Cancer with prior 223Ra treatment: the RALU study

Download full text files

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Kambiz Rahbar, Markus Essler, Kim M. Pabst, Matthias Eiber, Christian la Fougère, Vikas Prasad, Philipp Rassek, Ergela Hasa, Helmut Dittmann, Ralph Alexander Bundschuh, Wolfgang P. Fendler, Milena Kurtinecz, Anja Schmall, Frank Verholen, Oliver Sartor
URN:urn:nbn:de:bvb:384-opus4-1057224
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/105722
ISSN:0161-5505OPAC
ISSN:2159-662XOPAC
Parent Title (English):Journal of Nuclear Medicine
Publisher:Society of Nuclear Medicine
Place of publication:New York, NY
Type:Article
Language:English
Year of first Publication:2022
Publishing Institution:Universität Augsburg
Release Date:2023/07/25
Tag:Radiology, Nuclear Medicine and imaging
Volume:64
Issue:4
First Page:574
Last Page:578
DOI:https://doi.org/10.2967/jnumed.122.264456
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Nuklearmedizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):CC-BY 4.0: Creative Commons: Namensnennung (mit Print on Demand)